Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$2.74B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.61B |
| 3 |
Microsoft
MSFT
|
+$1.16B |
| 4 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.02B |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$834M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.58B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.54B |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.5B |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$639M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$552M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.13% |
| 2 | Financials | 8.44% |
| 3 | Consumer Discretionary | 7.61% |
| 4 | Healthcare | 7.43% |
| 5 | Industrials | 5.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
Silicon Motion
SIMO
$9.07B
| $19.4M | ﹤0.01% |
316,294
+272,103
| +616% | +$15.6M |
|
1927
Cleveland-Cliffs
CLF
$6.98B
| $19.4M | ﹤0.01% |
948,859
+480,089
| +102% | +$8.22M |
|
1928
Cushman & Wakefield Ltd
CWK
$3.2B
| $19.4M | ﹤0.01% |
1,793,914
-108,649
| -6% | -$905K |
|
1929
Silicon Laboratories
SLAB
$7.21B
| $19.4M | ﹤0.01% |
146,352
-21,719
| -13% | -$2.38M |
|
1930
Immunovant
IMVT
$8.2B
| $19.3M | ﹤0.01% |
458,131
-52,309
| -10% | -$1.92M |
|
1931
BioNTech
BNTX
$22.9B
| $19.3M | ﹤0.01% |
182,878
+42,177
| +30% | +$4.25M |
|
1932
Ionis Pharmaceuticals
IONS
$9.06B
| $19.3M | ﹤0.01% |
381,382
+43,555
| +13% | +$2.09M |
|
1933
Wolfspeed
WOLF
$1.43B
| $19.3M | ﹤0.01% |
443,380
+185,797
| +72% | +$6.74M |
|
1934
Commault Systems
CVLT
$5.53B
| $19.3M | ﹤0.01% |
241,171
-70,938
| -23% | -$5.07M |
|
|
TSVT
1935
DELISTED
2seventy bio
TSVT
| $19.3M | ﹤0.01% |
4,508,800
+3,772,556
| +512% | +$11.6M |
|
1936
CALL
Datadog
DDOG
$81.6B
| $19.2M | ﹤0.01% |
158,400
-265,200
| -63% | -$27.3M |
|
1937
CALL
Vertiv
VRT
$106B
| $19.2M | ﹤0.01% |
400,000
| – | – |
|
1938
Macerich
MAC
$6.66B
| $19.2M | ﹤0.01% |
1,244,970
+1,254
| +0.1% | +$14.9K |
|
1939
PUT
Bristol-Myers Squibb
BMY
$131B
| $19.2M | ﹤0.01% |
373,700
+76,100
| +26% | +$3.99M |
|
|
SP
1940
DELISTED
SP Plus Corporation
SP
| $19.2M | ﹤0.01% |
373,833
+290,403
| +348% | +$14.6M |
|
|
GOOS
1941
Canada Goose Holdings
GOOS
$837M
| $19.1M | ﹤0.01% |
1,615,335
+193,977
| +14% | +$2.29M |
|
1942
Vail Resorts
MTN
$5.23B
| $19.1M | ﹤0.01% |
89,668
+23,927
| +36% | +$5.24M |
|
1943
Werner Enterprises
WERN
$2.21B
| $19.1M | ﹤0.01% |
451,506
-126,862
| -22% | -$4.97M |
|
1944
CALL
Caesars Entertainment
CZR
$6.12B
| $19.1M | ﹤0.01% |
+406,800
| New | +$18.1M |
|
1945
Annaly Capital Management
NLY
$17.1B
| $19M | ﹤0.01% |
982,110
-72,583
| -7% | -$1.29M |
|
1946
CALL
Teck Resources
TECK
$32.4B
| $19M | ﹤0.01% |
450,000
+308,100
| +217% | +$11.8M |
|
1947
Chewy
CHWY
$9.59B
| $19M | ﹤0.01% |
804,765
-452,572
| -36% | -$8.92M |
|
1948
Antero Midstream
AM
$10.2B
| $19M | ﹤0.01% |
1,513,473
+507,577
| +50% | +$6.4M |
|
1949
Graham Holdings Company
GHC
$5.06B
| $18.9M | ﹤0.01% |
27,157
-1,049
| -4% | -$653K |
|
1950
Thor Industries
THO
$4.04B
| $18.9M | ﹤0.01% |
159,903
-150,972
| -49% | -$15.1M |
|
Similar funds
Goldman Sachs's Q4 2023 Portfolio in Review
As of Q4 2023, Goldman Sachs held 6,018 positions worth $543B, up 15% from $470B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Goldman Sachs deployed $17.8B of net new capital in Q4 2023, opening 537 new positions and adding to 2,390 existing holdings. Its largest new stake was Goldman Sachs MarketBeta Russell 1000 Value Equity ETF: 9,747,656 shares worth $415M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $1.58B trimmed.
- Goldman Sachs's largest Q4 2023 buy was Goldman Sachs MarketBeta Russell 1000 Value Equity ETF: 9,747,656 shares worth $415M.
- Goldman Sachs added most to iShares Core S&P 500 ETF in Q4 2023, an estimated $2.74B increase.
- Goldman Sachs's biggest Q4 2023 reduction was Apple, cutting an estimated $1.58B.
- Goldman Sachs fully exited Activision Blizzard in Q4 2023, selling an estimated $639M.
- Goldman Sachs's ten largest holdings make up 18% of its $543B portfolio in Q4 2023.
- Goldman Sachs opened 537 new positions and closed 416 in Q4 2023.
- Goldman Sachs's portfolio value rose 15% quarter-over-quarter to $543B.
Based on Goldman Sachs's 13F filing for Q4 2023, filed 13 Feb 2024.